However, large cohort clinical studies have recently shown that low circulating PRL levels are associated with metabolic disease, whereas high PRL levels acts on the pancreas, liver, adipose tissue, and hypothalamus to maintain and promote metabolic homeostasis (Macotela et al., 2022; Macotela et al., 2020). Here, PRL is linked to Other metabolic disease.